Par Drugs And Chemicals Limited Asset Resilience Ratio

Latest as of March 2024: 3.08%

Par Drugs And Chemicals Limited asset resilience ratio. Par Drugs And Chemicals Limited (PAR) has an Asset Resilience Ratio of 3.08% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Par Drugs And Chemicals Limited liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs31.31 Million
≈ $338.56K USD Cash + Short-term Investments

Total Assets

Rs1.02 Billion
≈ $10.99 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Par Drugs And Chemicals Limited (2019–2024)

Asset resilience ratio of Par Drugs And Chemicals Limited from 2019 to 2024. This chart shows how Par Drugs And Chemicals Limited's Asset Resilience Ratio has changed over time. Read debt load of Par Drugs And Chemicals Limited for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Par Drugs And Chemicals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Par Drugs And Chemicals Limited.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs0.00 0%
Short-term Investments Rs31.31 Million 3.08%
Total Liquid Assets Rs31.31 Million 3.08%

Asset Resilience Insights

  • Limited Liquidity: Par Drugs And Chemicals Limited maintains only 3.08% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Par Drugs And Chemicals Limited Industry Peers by Asset Resilience Ratio

Compare Par Drugs And Chemicals Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
Drug Manufacturers - Specialty & Generic 26.45%
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211
Drug Manufacturers - Specialty & Generic 11.84%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Renhe Pharmacy Co Ltd
SHE:000650
Drug Manufacturers - Specialty & Generic 37.54%
Bide Pharmatech Co. Ltd. A
SHG:688073
Drug Manufacturers - Specialty & Generic 9.46%
Jianmin Pharmaceutical Group Co Ltd
SHG:600976
Drug Manufacturers - Specialty & Generic 20.61%
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
Drug Manufacturers - Specialty & Generic 30.38%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.42%

Par Drugs And Chemicals Limited Asset Resilience Ratio by Year (2019–2024)

Par Drugs And Chemicals Limited asset resilience ratio by year from 2019 to 2024. The table below shows the annual Asset Resilience Ratio data for Par Drugs And Chemicals Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-03-31 0.00% Rs1.00K
≈ $10.81
Rs1.02 Billion
≈ $10.99 Million
-3.38pp
2023-03-31 3.38% Rs30.02 Million
≈ $324.61K
Rs888.68 Million
≈ $9.61 Million
+2.10pp
2022-03-31 1.27% Rs10.02 Million
≈ $108.32K
Rs786.90 Million
≈ $8.51 Million
+1.27pp
2019-03-31 0.00% Rs150.00
≈ $1.62
Rs513.55 Million
≈ $5.55 Million
--
pp = percentage points

About Par Drugs And Chemicals Limited

NSE:PAR India Drug Manufacturers - Specialty & Generic
Market Cap
$15.06 Million
Rs1.39 Billion INR
Market Cap Rank
#25817 Global
#1426 in India
Share Price
Rs113.20
Change (1 day)
+3.91%
52-Week Range
Rs78.58 - Rs168.25
All Time High
Rs348.45
About

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, m… Read more